aTyr Pharma (LIFE) Misses Q4 EPS by 1c

aTyr Pharma (NASDAQ: LIFE) reported Q4 EPS of ($0.25), $0.01 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c